Merck (MRK) FDA Approval of V114 Brings Blockbuster Potential - BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Merck & Co. (NYSE: MRK) | Delayed: 148.80 +4.13 (2.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.67 | 52 Week High | $65.46 | |||
| Open | $148.54 | 52 Week Low | $47.97 | |||
| Day High | $148.99 | P/E | 101.22 | |||
| Day Low | $146.05 | EPS | $1.47 | |||
| Volume | 3,349,106 | |||||
